Skip to content

News Releases

News Releases
  Date Title and Summary View
Oct 18, 2018
NEW BRUNSWICK, N.J., Oct. 18, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2018 of $0.90 per share on the company's common stock.  The dividend is payable on December 11, 2018 to shareholders of record at the close of business on November 27, 20...
Oct 16, 2018
NEW BRUNSWICK, N.J., Oct. 16, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced sales of $20.3 billion for the third quarter of 2018, an increase of 3.6% as compared to the third quarter of 2017. Operational sales results increased 5.5%, partially offset by the negative impact of currency of 1.9%. Domestic sales increased 3.6%. Int...
Oct 10, 2018
Oct 9, 2018
Oct 4, 2018
Oct 2, 2018
NEW BRUNSWICK, N.J., Oct. 2, 2018 /CNW/ -- Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its LifeScan business to Platinum Equity for approximately $2.1 billion. LifeScan, Inc. is a world leader in blood glucose monitoring and maker of the OneTouch® brand of products. It generated net revenues of ap...
Sep 27, 2018
HORSHAM, Pa., Sept. 27, 2018 /PRNewswire/ -- Janssen Biotech, Inc. (Janssen) announced today its decision not to continue the collaboration and license agreement with Geron Corporation for imetelstat. The decision not to continue the collaboration is the result of a strategic portfolio evaluation and prioritization of assets within the robust Janss...
Sep 26, 2018
Sep 21, 2018
TITUSVILLE, N.J., Sept. 21, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from a Phase 3 clinical study of the investigational product esketamine nasal spray in patients with treatment-resistant depression. Janssen researchers presented these results at the Ninth Biennial Conference of the In...
Sep 19, 2018
NEW BRUNSWICK, N.J., Sept. 19, 2018 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 16th, to review third-quarter results.  Joseph J. Wolk, Executive Vice President, Chief Financial Officer and Christopher DelOrefice, Vice President, Investor Relations will host...
... NextLast
= add release to Briefcase